Business ❯Pharmaceutical Companies

Novo Nordisk

Wegovy Semaglutide Earnings Market Capitalization Sales Ozempic Novo Holdings Drug Pricing Eli Lilly Drug Pricing Strategies Product Portfolio Market Strategies Products

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

As more people use GLP-1 medications for obesity, shortages impact diabetes patients' access to these critical drugs.

Bernie Sanders Targets Novo Nordisk Over High U.S. Drug Prices

Eli Lilly Faces Zepbound Shortage, Impacting Weight Loss and Diabetes Patients

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results

Novo Nordisk Expands Production Capacity with $16.5 Billion Catalent Acquisition

Novo Nordisk Boosts Wegovy Supply Amid Soaring Demand and Competition

Novo Nordisk Inks $1.1B Research Deals with Omega Therapeutics and Cellarity